Significance and relationship between DJ-1 gene and survivin gene expression in laryngeal squamous cell carcinoma

European Journal of Histochemistry

Volumn 55, Issue 1, 2011, Pages 50-54

  Shen, Z ^a   Ren, Y ^a   Ye, D ^a   Guo, J ^a   Kang, C ^a   Ding, H ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Diagnosis; DJ 1 gene; Laryngeal carcinoma; Surviving gene

Indexed keywords

BIRC5 PROTEIN, HUMAN; DJ 1 PROTEIN, MOUSE; DJ-1 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; ONCOPROTEIN;

ARTICLE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX TUMOR; METABOLISM; SQUAMOUS CELL CARCINOMA; SURVIVAL; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; LARYNGEAL NEOPLASMS; ONCOGENE PROTEINS; SURVIVAL ANALYSIS;

EID: 79958210823     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2011.e9     Document Type: Article

References (24)

1. Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 2008;41:673-95.
2. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-9.
3. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-73.
4. Shi W, Zhang X, Pintilie M, Ma N, Miller N, Banerjee D, et al. Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer 2003;104:195-203.
5. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S, et al. Proteomicsbased identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 2001;7:3328-35.
6. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y,Ting JP. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 2003;63:6928-34.
7. Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007;28:1133-9.
8. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM,Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007;249:49-60.
9. Shen J, Liu J, Long Y, Miao Y, Su M, Zhang Q, et al. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity. Acta Biochim Biophys Sin (Shanghai) 2009;41:223-30.
10. Andersen MH, Svane IM, Becker JC, Straten PT. The universal character of the tumor-associated antigen survivin. Clin Cancer Res 2007;13:5991-4.
11. Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of surviving in myeloid leukemia. Blood 2001;97: 2784-90.
12. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, et al. Survivin initiates ell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 2000;19:3225-34.
13. Wu RC, Li X, Schonthal AH. Trans-criptional activation of p21WAF1 by PTEN /MMAC1 tumor suppressor. Mol Cell Biochem 2000;203:59-71.
14. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 2000;19:1346-53.
15. Shen Z, Jiang Z, Ye D, Xiao B, Zhang X, Guo J. Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells. Med Oncol 2010 [Epub ahead of print].
16. Zhu XL, Wen WP, Lei WB, Chai LP, Hou WJ, Wen YH, et al. DJ-1 expression in laryngeal squamous cell carcinoma and its relationship with tumor recurrence and metastasis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010;45:497-501.
17. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 2007;104:320-5.
18. Arnouk H, Merkley MA, Podolsky RH, Stoppler H, Santos C, Alvarez M, et al. Characterization of Molecular Markers Indicative of Cervical Cancer Progression. Proteomics Clin Appl 2009;3:516-27.
19. Wu F, Liang YQ, Huang ZM. The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis. Zhonghua Gan Zang Bing Za Zhi 2009;17:203-6.
20. Landon MR, Lieberman RL, Hoang QQ, Ju S, Caaveiro JM, Orwig SD, et al. Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase. J Comput Aided Mol Des. 2009 [Epub ahead of print].
21. Kawasaki H, Toyoda M, Shinohara H, Okuda J, Watanabe I, Yamamoto T, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 2001;91:2026-32.
22. Wang Y, Kong W, Xiong X, Zhang S, Sun D. The expressions of survivin and VEGF in squamous cell carcinoma of larynx and the correlation between the two marks. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005;19:838-41.
23. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002;22:2377-83.
24. Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, et al. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer 2009;125:783-90.